glp 1 blue cross blue shield of Massachusetts will stop covering popular GLP-1 weight-loss drugs like Ozempic and Wegovy starting January 1, 2026. The decision comes as the costs for these medications have A handful of nonprofit Blue

This has happened around alcohol-free beer and other nolo drinks

Pharmacies warn the bill could overreach Compounding advocates and some pharmacists told lawmakers they see the bill as a heavy regulatory lift that risks stepping on federal turf

Thats because Medicare now covers the drugs, known as GLP-1s, for other medically accepted indications, including to treat diabetes

Because Mounjaro can produce more significant weight loss than other GLP-1 medications, the risk of associated hair shedding may be higher in some individuals

doi: 10.1177/1060028017689878 [DOI] [PubMed] [Google Scholar] 128

Mller TD, Nogueiras R, Andermann ML, et al